Search

everythinglearnresearchcommunity

for

Search:↓

Flutamide is more effective and has fewer side effects than spironolactone for treating hirsutism.

The normal human prostate does not significantly affect blood DHT levels.

Testosterone therapy can modestly improve sexual function in menopausal women but should be used cautiously and is not recommended for routine measurement in sexual dysfunction or hirsutism.

Hirsutism is too much hair growth in women like the pattern in men, often caused by high male hormones, and can be treated with hormone control and hair removal methods.

A new treatment called SAMiRNA-AR68 increases hair count in people with hair loss, showing similar results to existing treatments but without side effects.

Hair ages due to various factors and treatments like minoxidil and finasteride can help, but more research and better public awareness are needed.

Hirsutism is often caused by high male hormone levels and can be treated with lifestyle changes and medications.

Hormonal interactions, especially involving DHT and estrogen, play a key role in BPH development and treatment.

Certain genetic variants increase the risk of resistance to hormone therapy in prostate cancer patients.

Hirsutism is excessive hair growth in women often caused by polycystic ovarian syndrome, and identifying the cause is important for managing associated health risks.

Insulin resistance is a key factor in polycystic ovary syndrome, but genetics may also contribute.

The document concludes that for hair and feather growth, it's better to target the environment around stem cells than the cells themselves.

Progesterone initially worsens but later reduces neuropathic pain in mice, through different mechanisms.

New treatments for hair loss should target eight main causes and use specific plant compounds and peptides for better results.

The new anti-acne treatment HA-P5 effectively reduces acne by targeting two key receptors and avoids an enzyme that can hinder treatment.

Hormones cause hair loss by affecting cell growth and weakening cell attraction.

Testosterone treatment in trans men increases body and facial hair and may lead to hair loss over time, but severe skin issues are rare.

Androgens reduce BMP2, which weakens the ability of certain cells to help hair stem cells become different types of cells.

Honokiol might help reduce male skin aging by maintaining testosterone levels.

Hair loss can be treated with medications like minoxidil and finasteride or surgery, but treatment effectiveness varies by alopecia type and accurate diagnosis is important.

FGF signaling is a promising target for developing treatments for wounds, metabolic diseases, and cancer.

Early balding men may have insulin resistance, but lifestyle changes can help.

Nanoparticles can be used to deliver drugs to hair follicles, potentially improving treatments for conditions like acne and alopecia, and could also be used for vaccine delivery and gene therapy.

Dianabol boosts muscle growth but has serious health risks and legal issues.

Hair loss linked to higher heart disease risk in both men and women.

Prolactin affects hair growth and skin conditions, and could be a target for new skin disease treatments.

Wnt signaling is crucial for skin and hair development and its disruption can cause skin tumors.

Blocking the prolactin receptor might help treat various diseases, but more research is needed.

The testosterone patch and gel are both effective, but they have different absorption patterns and effects on hormone levels.

Severe baldness on the top of the head is linked to a higher chance of heart disease, especially in men under 60.